Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02106091 |
|
Recruitment Status :
Terminated
(Non-favorable risk/benefit profile with studied dosing regimen)
First Posted : April 8, 2014
Last Update Posted : June 18, 2019
|
Sponsor:
Affimed GmbH
Information provided by (Responsible Party):
Affimed GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | August 2018 |
| Actual Study Completion Date : | September 2018 |